Codice QR

Heterologous Omicron-adapted vaccine as a secondary booster promotes neutralizing antibodies against Omicron and its sub-lineages in mice

Over one billion people have received 2–3 dosages of an inactivated COVID-19 vaccine for basic immunization. Whether a booster dose should be delivered to protect against the Omicron variant and its sub-lineages, remains controversial. Here, we tested different vaccine platforms targeting the ancest...

Descrizione completa

Salvato in:
Autori principali: Jianyang Liu, Qian He, Fan Gao, Lianlian Bian, Qian Wang, Chaoqiang An, Lifang Song, Jialu Zhang, Dong Liu, Ziyang Song, Lu Li, Yu Bai, Zhongfang Wang, Zhenglun Liang, Qunying Mao, Miao Xu
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis Group 2023-12-01
Serie:Emerging Microbes and Infections
Soggetti:
COVID-19
Omicron variant
booster vaccine
neutralizing antibody
heterologous vaccination
Accesso online:https://www.tandfonline.com/doi/10.1080/22221751.2022.2143283
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi